Showing results (531-540 of 810) with videos related to

Sort By:
Pageof 81
Circulation|June 18, 2021
Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery DiseaseMichael G Levin, Verena Zuber, Venexia M Walker, et al.
Journal of Clinical Lipidology|October 2, 2013
High-density lipoproteins: a consensus statement from the National Lipid AssociationPeter P Toth, Philip J Barter, Robert S Rosenson, et al.
European Heart Journal|March 19, 2011
The novel atherosclerosis locus at 10q11 regulates plasma CXCL12 levelsNehal N Mehta, Mingyao Li, Dilusha William, et al.
BMC Nephrology|February 22, 2019
Insulin resistance and chronic kidney disease progression, cardiovascular events, and death: findings from the chronic renal insufficiency cohort studySarah J Schrauben, Christopher Jepson, Jesse Y Hsu, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
Contextualizing molecular and structural aging across human organsJuan Shu, Yuxin Guo, Julio Chirinos, et al.
American Journal of Nephrology|April 29, 2011
Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) StudyRaymond R Townsend, Amanda H Anderson, Jing Chen, et al.
Journal of the American College of Cardiology|January 13, 2018
NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic StenosisSotirios Tsimikas, Sergio Fazio, Keith C Ferdinand, et al.
Nature Medicine|March 6, 2023
Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trialRobert S Rosenson, Daniel Gaudet, Christie M Ballantyne, et al.
HGG Advances|August 26, 2024
Facilitating return of actionable genetic research results from a biobank repository: Participant uptake and utilization of digital interventionsLillian Phung, Elisabeth Wood, Brian Egleston, et al.
Acta Pharmacologica Sinica|May 15, 2023
JMJD6 protects against isoproterenol-induced cardiac hypertrophy via inhibition of NF-κB activation by demethylating R149 of the p65 subunitZhen Guo, Yue-Huai Hu, Guo-Shuai Feng, et al.
Pageof 81